Airbufo Forspiro vs Seffalair Spiromax: Side-by-Side Comparison
Quick answer: Airbufo Forspiro and Seffalair Spiromax are both inhaled corticosteroid + long-acting beta2-agonist combination used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Airbufo Forspiro | Seffalair Spiromax |
|---|---|---|
| Drug class | Inhaled corticosteroid + long-acting beta2-agonist combination | Inhaled corticosteroid + long-acting beta2-agonist combination |
| ATC code | R03AK07 | R03AK10 |
| Primary indications | Asthma, Chronic obstructive pulmonary disease | Asthma |
| Mechanism | Budesonide (anti-inflammatory glucocorticoid) combined with formoterol (long-acting beta2-agonist bronchodilator) delivered via Forspiro dry powder inhaler | Fluticasone propionate suppresses airway inflammation while salmeterol provides sustained bronchodilation via beta2-adrenergic stimulation |
| Common dose | 1-2 inhalations twice daily (strength-dependent) | 1 inhalation twice daily (fluticasone 55 or 113 mcg / salmeterol 14 mcg) |
| Detail page | Airbufo Forspiro details → | Seffalair Spiromax details → |
How to choose between Airbufo Forspiro and Seffalair Spiromax
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Inhaled corticosteroid + long-acting beta2-agonist combination on iMedic · Airbufo Forspiro full details · Seffalair Spiromax full details
Frequently asked questions
Is Airbufo Forspiro better than Seffalair Spiromax?
Neither is universally 'better.' They are both inhaled corticosteroid + long-acting beta2-agonist combination with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Airbufo Forspiro to Seffalair Spiromax?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Airbufo Forspiro and Seffalair Spiromax have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Airbufo Forspiro and Seffalair Spiromax available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.